FDA Adverse Event Injury Summary report: N

OT ULTRALINK METER

MDR report key: 3198271 · Received July 1, 2013

Report

Report Number
3008382007-2013-18728
Event Type
Injury
Date Received
July 1, 2013
Report Date
June 7, 2013
Manufacturer
LIFESCAN EUROPE, A DIVISION OF CILAG GMBH INTL
Product Code
NBW
PMA / PMN Number
K073231
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CT, US
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

THE METER AND TEST STRIPS (LOT# 3397323 AND 3354650) INVOLVED WITH THIS COMPLAINT HAVE BEEN RETURNED TO LFS AND EVALUATED BY PRODUCT ANALYSIS (PA) ON (B)(4) 2013 RESPECTIVELY WITH THE FOLLOWING FINDINGS: THE ALLEGED INACCURATE READING WAS NOTED ON THE METER MEMORY BUT PA COULD NOT REPRODUCE FAILURE IN TEST. THE TEST STRIPS PASSED ALL TESTING WITH NO FAULTS FOUND. IF LIFESCAN OBTAINS ADDITIONAL INFORMATION REGARDING THIS COMPLAINT, A SUPPLEMENTAL REPORT WILL BE SUBMITTED. AT THIS TIME, LIFESCAN CONSIDERS THIS MATTER CLOSED.

Description of Event or Problem · 1

ON (B)(6) 2013 THE LAY USER/PATIENT CONTACTED LIFESCAN (LFS) ALLEGING HER ONETOUCH ULTRALINK METER WAS DISPLAYING INACCURATELY HIGH READINGS COMPARED ANOTHER METER. THE COMPLAINT WAS CLASSIFIED BASED ON THE CUSTOMER CARE ADVOCATE (CCA) DOCUMENTATION. THE PATIENT REPORTED THE ALLEGED ISSUE FIRST OCCURRED ON (B)(6) 2013 AT 1 PM. THE PATIENT ALLEGED OBTAINING READINGS OF ¿224 MG/DL¿ COMPARED TO ¿160, 260, AND 235 MG/DL¿ ON A DOCTOR¿S TRUE RESULT METER. THE PATIENT REPORTED USING INSULIN PUMP THERAPY TO MANAGE HER DIABETES. THE PATIENT REPORTED ON (B)(6) 2013 AT 1 PM, SHE TOOK A DECREASED DOSE OF APIDRA INSULIN. THE PATIENT REPORTED 3 HOURS AFTER THE ALLEGED ISSUE BEGAN SHE FELT SYMPTOMS OF ¿HYPOGLYCEMIA, LIGHT HEADED AND LOW BLOOD GLUCOSE¿ AND SHE WAS TAKEN TO THE HOSPITAL. THE PATIENT REPORTED SHE WAS TREATED WITH IV GLUCOSE ON (B)(6) AT 1 PM BY A HEALTHCARE PROFESSIONAL. AT THE TIME OF TROUBLESHOOTING, THE CCA CONFIRMED THE METER WAS IN THE CORRECT UNIT OF MEASUREMENT AT THE TIME OF TESTING AND THE PATIENT WAS USING AN APPROVED SAMPLE SITE TO OBTAIN THE BLOOD SAMPLE. REPLACEMENT PRODUCTS WERE SENT TO THE PATIENT. THIS COMPLAINT IS BEING REPORTED AS AN ADVERSE EVENT BECAUSE THE PATIENT CLAIMS DUE TO THE ALLEGED ISSUE SHE DEVELOPED SYMPTOMS SUGGESTIVE OF HYPOGLYCEMIA AND REQUIRED TREATMENT FROM A HEALTHCARE PROFESSIONAL.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
297931 OT ULTRALINK METER GLUCOSE MONITORING SYS/KIT NBW LIFESCAN EUROPE, A DIVISION OF CILAG GMBH INTL 3397323

Patients

Seq Age Sex Outcome Treatment
1 70 YR Hospitalization| L| R